2018
Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder
Carroll KM, Nich C, Frankforter TL, Yip SW, Kiluk BD, DeVito EE, Sofuoglu M. Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder. Drug And Alcohol Dependence 2018, 192: 264-270. PMID: 30300800, PMCID: PMC6203294, DOI: 10.1016/j.drugalcdep.2018.08.019.Peer-Reviewed Original ResearchConceptsOpioid use disorderOral naltrexoneUse disordersAffective symptomsVoucher-based contingency managementDysphoric symptomsAffective distressOral naltrexone treatmentMultiple baseline characteristicsBaseline characteristicsNaltrexone treatmentHigh riskNaltrexoneSomatic symptomsSymptomsContingency managementTreatmentHigh rateDistressSubstantial evidenceTrialsTheoretical benefitsDisordersAffective discomfortParticipantsObsessive-compulsive and related disorders.
Tolin D, Springer K. Obsessive-compulsive and related disorders. 2018, 455-479. DOI: 10.1037/0000064-019.Peer-Reviewed Original ResearchObsessive-compulsive disorderCognitive behavioral therapyBody dysmorphic disorderFifth editionPsychological modelsDysmorphic disorderReview researchDSM-5First-line interventionRelated disordersExcoriation disorderStatistical ManualOCRDsSomatic treatmentsDisordersTreatment outcomesSubstantial evidenceCompulsionObsessionTrichotillomaniaSymptomsAssociated burdenEditionInterventionClear need
2009
Corneal aldehyde dehydrogenases: Multiple functions and novel nuclear localization
Stagos D, Chen Y, Cantore M, Jester JV, Vasiliou V. Corneal aldehyde dehydrogenases: Multiple functions and novel nuclear localization. Brain Research Bulletin 2009, 81: 211-218. PMID: 19720116, PMCID: PMC3025408, DOI: 10.1016/j.brainresbull.2009.08.017.Peer-Reviewed Original ResearchConceptsException of rabbitsCorneal epitheliumOcular tissuesMouse corneaProtective roleUVR exposureCorneaMessenger levelsNuclear presenceOxidative damageCorneal crystallinsSubstantial evidenceNovel nuclear localizationALDH3A1Rabbit keratocytesReactive aldehydesCell cycle regulationAntioxidant activityGene expressionALDHMost mammalsCycle regulationExogenous aldehydesNuclear localizationALDH1A1
2008
Pharmaceutical Industry Marketing: Understanding Its Impact on Women’s Health
Sufrin CB, Ross JS. Pharmaceutical Industry Marketing: Understanding Its Impact on Women’s Health. Obstetrical & Gynecological Survey 2008, 63: 585-596. PMID: 18713478, DOI: 10.1097/ogx.0b013e31817f1585.Commentaries, Editorials and LettersConceptsWomen's healthOral contraceptive pillsEvidence-based careHealth carePremenstrual dysphoric disorderPharmaceutical marketingContraceptive pillsDysphoric disorderModern health carePhysician behaviorCytology techniqueConsumer advertisingCarePatientsHealthPhysiciansSubstantial evidenceSignificant involvementPractice of medicineDrugsDiscussion of guidelinesProphylaxisProfessional organizationsPillsWomen
2004
Regulation of affect by the lateral septum: implications for neuropsychiatry
Sheehan T, Chambers R, Russell D. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Research Reviews 2004, 46: 71-117. PMID: 15297155, DOI: 10.1016/j.brainresrev.2004.04.009.Peer-Reviewed Original ResearchConceptsLateral septumAdministration of antipsychoticsDepression-like phenotypeMesocorticolimbic dopamine systemMidbrain dopamine neuronsPsychotic spectrum disordersLS neuronsDopamine neuronsBlunted activityL-neuronsDopamine systemPsychiatric conditionsHippocampal inputsVentral striatumBest treatmentNeuronsNeural activityBehavioral manifestationsSubstantial evidenceAffective functionsSeptumSpectrum disorderMolecular studiesRegulation of affectCritical role
2000
Alcohol and Eating Disorders: Implications for Alcohol Treatment and Health Services Research
Sinha R, O'Malley S. Alcohol and Eating Disorders: Implications for Alcohol Treatment and Health Services Research. Alcohol Clinical And Experimental Research 2000, 24: 1312-1319. PMID: 10968671, DOI: 10.1111/j.1530-0277.2000.tb02097.x.Peer-Reviewed Original ResearchConceptsHealth services research perspectivePossible etiologic associationAlcohol use disorderHealth services researchClinical manifestationsEtiologic associationAlcoholic womenPsychiatric disordersUse disordersAlcohol treatmentClinical implicationsBehavioral treatmentDisordersTreatment implicationsEating DisordersAlcoholismComorbiditiesWomenHigh rateServices researchSubstantial evidenceExpected ratesTreatmentReview
1999
Role of Angiotensin II in Coagulation and Fibrinolysis
Brown N, Vaughan D. Role of Angiotensin II in Coagulation and Fibrinolysis. Heart Failure Reviews 1999, 3: 193-198. DOI: 10.1023/a:1009757416302.Peer-Reviewed Original ResearchAntithrombotic effectAngiotensin type 1 receptor antagonistType 1 receptor antagonistVascular fibrinolytic balanceRenin-angiotensin systemTissue plasminogen activatorHypertensive patientsInhibitor PAI-1Angiotensin IIFibrinolytic balanceReceptor antagonistVasculoprotective propertiesPlatelet functionEnzyme inhibitorsPAI-1Plasminogen activatorMultiple mechanismsFibrinolysisSubstantial evidenceRecent studiesAngiotensinPatientsProstanoidsAntagonist
1997
PATHOGENESIS OF ENDOMETRIOSIS
Oral E, Arici A. PATHOGENESIS OF ENDOMETRIOSIS. Obstetrics And Gynecology Clinics Of North America 1997, 24: 219-233. PMID: 9163764, DOI: 10.1016/s0889-8545(05)70301-6.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply